Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts.
about
Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinomaLiver regeneration microenvironment of hepatocellular carcinoma for prevention and therapyCellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.
P2860
Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@en
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@nl
type
label
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@en
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@nl
prefLabel
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@en
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@nl
P2093
P2860
P356
P1476
Using multiple cytokines to pr ...... rrence in two patient cohorts.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.781
P407
P577
2013-12-17T00:00:00Z